ZA982447B - A method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis - Google Patents

A method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis

Info

Publication number
ZA982447B
ZA982447B ZA982447A ZA982447A ZA982447B ZA 982447 B ZA982447 B ZA 982447B ZA 982447 A ZA982447 A ZA 982447A ZA 982447 A ZA982447 A ZA 982447A ZA 982447 B ZA982447 B ZA 982447B
Authority
ZA
South Africa
Prior art keywords
tuberculosis
containment
aerosol formulation
treatment prevention
tobramycin aerosol
Prior art date
Application number
ZA982447A
Other languages
English (en)
Inventor
Alan Bruce Montgomery
Original Assignee
Pathogenesis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pathogenesis Corp filed Critical Pathogenesis Corp
Publication of ZA982447B publication Critical patent/ZA982447B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA982447A 1997-04-02 1998-03-23 A method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis ZA982447B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/825,725 US6083922A (en) 1996-04-02 1997-04-02 Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis

Publications (1)

Publication Number Publication Date
ZA982447B true ZA982447B (en) 1999-01-26

Family

ID=25244769

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA982447A ZA982447B (en) 1997-04-02 1998-03-23 A method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis

Country Status (7)

Country Link
US (1) US6083922A (xx)
AR (1) AR011706A1 (xx)
AU (1) AU6469198A (xx)
BR (1) BR9801008A (xx)
IL (1) IL123848A (xx)
WO (1) WO1998043650A1 (xx)
ZA (1) ZA982447B (xx)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW465235B (en) 1998-09-17 2001-11-21 United Video Properties Inc Electronic program guide with digital storage
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
WO2002072169A2 (en) * 2001-03-09 2002-09-19 Antares Pharma, Inc. Ocular drug delivery nebulizer
AU2007202942B2 (en) * 2001-05-18 2010-05-27 Novartis Ag Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
CA2447600C (en) 2001-05-18 2015-10-20 Chiron Corporation Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
EP1598059A1 (en) * 2001-05-18 2005-11-23 Chiron Corporation Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
WO2003037365A1 (en) * 2001-11-01 2003-05-08 The Johns Hopkins University Methods and compositions for treating vascular leak using hepatocyte growth factor
AU2003243191B2 (en) 2002-05-02 2007-09-20 President And Fellows Of Harvard College Formulations limiting spread of pulmonary infections
US20050220720A1 (en) * 2002-05-02 2005-10-06 David Edwards Formulations limiting spread of pulmonary infections
US7607436B2 (en) * 2002-05-06 2009-10-27 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
US7334580B2 (en) * 2002-05-07 2008-02-26 Smaldone Gerald C Methods, devices and formulations for targeted endobronchial therapy
US8545463B2 (en) 2003-05-20 2013-10-01 Optimyst Systems Inc. Ophthalmic fluid reservoir assembly for use with an ophthalmic fluid delivery device
US7883031B2 (en) 2003-05-20 2011-02-08 James F. Collins, Jr. Ophthalmic drug delivery system
WO2005037256A2 (de) * 2003-10-15 2005-04-28 Pari Gmbh Flüssige zubereitung enthaltend tobramycin
US20050207983A1 (en) * 2004-03-05 2005-09-22 Pulmatrix, Inc. Formulations decreasing particle exhalation
BRPI0509026A (pt) 2004-05-17 2007-09-18 Corus Pharma Inc formulação de aerossol, método para a prevenção e tratamento de infecção causada por bactéria do trato respiratório, e, solução
US8627821B2 (en) * 2005-01-10 2014-01-14 Pulmatrix, Inc. Method and device for decreasing contamination
US20060249144A1 (en) * 2005-05-05 2006-11-09 Pulmatrix Inc. Ultrasonic Aerosol Generator
PT1901749T (pt) 2005-05-18 2016-11-04 Raptor Pharmaceuticals Inc Fluoroquinolonas aerossolizadas e suas utilizações
EA016072B1 (ru) * 2005-05-18 2012-01-30 Палметрикс Инк. Применение состава соли кальция для изменения биофизических свойств слизистой оболочки
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
KR101424518B1 (ko) * 2005-09-29 2014-08-06 노바르티스 아게 항생제 제형, 단위 투여체, 키트 및 방법
WO2008013589A2 (en) 2006-04-24 2008-01-31 Gloucester Pharmaceuticals Treatment of ras-expressing tumors
US8957027B2 (en) 2006-06-08 2015-02-17 Celgene Corporation Deacetylase inhibitor therapy
EP2061772A4 (en) 2006-09-11 2011-06-29 Curis Inc MULTIFUNCTIONAL SMALL MOLECULES AS PROLIFERATION-ACTIVE ACTIVE SUBSTANCES
JP2008199905A (ja) * 2007-02-16 2008-09-04 Snow Brand Milk Prod Co Ltd 乳酸菌生残性向上剤
PL2344129T3 (pl) 2008-10-07 2018-07-31 Horizon Orphan Llc Formulacje fluorochinolonu w aerozolu dla poprawy właściwości farmakokinetycznych
JP2012505222A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 肺炎症を低減するためのレボフロキサシンの吸入
MY160130A (en) 2009-02-27 2017-02-28 Enanta Pharm Inc Hepatitis c virus inhibitors
DK2445502T4 (da) 2009-06-25 2022-11-28 Alkermes Pharma Ireland Ltd Heterocycliske forbindelser til behandling af neurologiske og psykologiske lidelser
US20110014273A1 (en) * 2009-07-15 2011-01-20 Helmut Brunar Method of Treating BCC
ES2739979T3 (es) 2009-09-04 2020-02-05 Horizon Orphan Llc Uso de levofloxacino en aerosol para el tratamiento de la fibrosis quística
JP6076740B2 (ja) 2010-01-07 2017-02-08 アルカーメス ファーマ アイルランド リミテッド 第四級アンモニウム塩プロドラッグ
AU2011270701B2 (en) 2010-06-24 2015-05-14 Alkermes Pharma Ireland Limited Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
US10154923B2 (en) 2010-07-15 2018-12-18 Eyenovia, Inc. Drop generating device
CA2805426C (en) 2010-07-15 2020-03-24 Corinthian Ophthalmic, Inc. Drop generating device
WO2012009696A2 (en) 2010-07-15 2012-01-19 Corinthian Ophthalmic, Inc. Ophthalmic drug delivery
CA2805635A1 (en) 2010-07-15 2012-01-19 Corinthian Ophthalmic, Inc. Method and system for performing remote treatment and monitoring
EP2448571B1 (en) 2010-08-30 2013-06-12 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
CN105640925B (zh) 2010-08-30 2019-08-16 普马特里克斯营业公司 干燥粉末配方及用于治疗肺部疾病的方法
EP2621488B1 (en) 2010-09-29 2018-11-07 Pulmatrix Operating Company, Inc. Cationic dry powders
AU2011308865B2 (en) 2010-09-29 2017-01-05 Pulmatrix, Inc. Monovalent metal cation dry powders for inhalation
AU2011348085B2 (en) 2010-12-23 2016-12-08 Alkermes Pharma Ireland Limited Multi- API loading prodrugs
TWI574687B (zh) 2011-01-03 2017-03-21 古利斯股份有限公司 具有鋅結合部份之刺蝟拮抗劑
DK2670242T3 (da) 2011-01-31 2022-05-02 Avalyn Pharma Inc Aerosolpirfenidon- og pyridonanalogforbindelser og anvendelser deraf
SG10201602569RA (en) 2011-04-01 2016-05-30 Curis Inc Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
EP2790619A1 (en) 2011-12-12 2014-10-22 Corinthian Ophthalmic, Inc. Ejector mechanism, ejector device, and methods of use
CA2858808C (en) 2011-12-15 2017-04-18 Alkermes Pharma Ireland Limited Samidorphan (alks 33) in combination with opioid agonists
JP5952912B2 (ja) 2011-12-15 2016-07-13 アルカーメス ファーマ アイルランド リミテッド 二級アミン化合物のプロドラッグ
NZ629722A (en) 2012-02-29 2017-03-31 Pulmatrix Operating Co Inc Inhalable dry powders
JP6501264B2 (ja) 2012-07-24 2019-04-17 アヴァリン ファーマ インク． エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用
US20140371238A1 (en) 2013-03-13 2014-12-18 Flatley Discovery Lab Compounds and methods for the treatment of cystic fibrosis
CN105324106A (zh) 2013-04-01 2016-02-10 普马特里克斯营业公司 噻托铵干粉
CA3172586A1 (en) 2013-07-31 2015-02-05 Avalyn Pharma Inc. Aerosol imatininb compounds and uses thereof
SG10201808565QA (en) 2014-03-31 2018-11-29 Debiopharm Int Sa Fgfr fusions
EP4112071A1 (en) 2014-08-26 2023-01-04 HSF Pharmaceuticals Novel immunization agents and methods of use
ES2971157T3 (es) 2014-10-06 2024-06-03 Apm Therapeutics 1 Inc Compuestos de triazolopiridina y métodos para el tratamiento de la fibrosis quística
EP3426245B1 (en) 2016-03-07 2022-12-14 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
US11597708B2 (en) 2016-09-16 2023-03-07 Hsf Pharmaceuticals Sa Inhibitors of heat shock factors and uses thereof
JP7227163B2 (ja) 2017-06-10 2023-02-21 アイノビア，インコーポレイティド 流体を取扱い、目に流体を送出するための方法および装置
WO2019110099A1 (en) 2017-12-06 2019-06-13 Qrumpharma Inc. Inhalable clofazimine formulation
WO2019170871A1 (en) 2018-03-08 2019-09-12 Hsf Pharmaceuticals Localized activation of virus replication boosts herpesvirus-vectored vaccines
AU2019267011A1 (en) 2018-05-10 2020-10-29 Cis Pharma Ag Biocompatible copolymer containing multiple active agent molecules
AU2019324330A1 (en) 2018-08-23 2021-03-04 Mannkind Corporation Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
CN112955142A (zh) 2018-09-21 2021-06-11 英安塔制药有限公司 官能化杂环化合物作为抗病毒剂
EP3653716A1 (en) 2018-11-19 2020-05-20 HSF Pharmaceuticals Replication-competent controlled alpha-herpesvirus virus vectors and uses therefore
CA3142101A1 (en) 2019-06-04 2020-12-10 Thirty Holdings Limited Methods and compositions for generating nitric oxide and uses thereof
CN114126629A (zh) 2019-06-04 2022-03-01 三十呼吸有限公司 用于生成一氧化氮的方法和组合物及其用于经由呼吸道输送一氧化氮的用途
BR112022008235A2 (pt) 2019-10-30 2022-07-12 Cis Pharma Ag Portadores de fármacos poliméricos biocompatíveis para a liberação de agentes ativos
CN115003296A (zh) 2019-12-05 2022-09-02 弗拉特利发现实验室有限责任公司 用于治疗囊肿状纤维化的化合物及其治疗方法
BR112022021454A2 (pt) 2020-04-23 2023-01-31 Thirty Respiratory Ltd Óxido nítrico ou composições liberadoras de óxido nítrico para uso no tratamento de sars-cov e sars-cov-2
EP4138794A1 (en) 2020-04-23 2023-03-01 Thirty Respiratory Limited Methods and compositions for treating and combatting tuberculosis
WO2021214279A1 (en) 2020-04-24 2021-10-28 Hsf Pharmaceuticals Replication-competent controlled herpesviruses expressing a sars cov-2 antigen
US20230270691A1 (en) 2020-06-01 2023-08-31 Advent Therapeutics, Inc. Pharmaceutical compositions comprising insoluble active ingredients
US20230233514A1 (en) 2020-06-23 2023-07-27 Flagship Pioneering, Inc. Antiviral compounds and methods of using the same
ES2936277R1 (es) 2020-07-20 2023-04-18 Enanta Pharm Inc Peptidos funcionalizados como agentes antivirales
CA3173333A1 (en) 2020-11-23 2022-05-27 Enanta Pharmaceuticals, Inc. Novel spiropyrrolidine derived antiviral agents
WO2022240897A1 (en) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung
WO2023006993A1 (en) 2021-07-30 2023-02-02 Atmosr Fused amino pyridine or pyrimidine derivatives for the treatment of congenital central hypoventilation syndrome
WO2023028364A1 (en) 2021-08-27 2023-03-02 Sepelo Therapeutics, Llc Targeted compositions and uses therof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
US5284133A (en) * 1992-07-23 1994-02-08 Armstrong Pharmaceuticals, Inc. Inhalation device with a dose-timer, an actuator mechanism, and patient compliance monitoring means
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization

Also Published As

Publication number Publication date
AR011706A1 (es) 2000-08-30
BR9801008A (pt) 2001-03-20
AU6469198A (en) 1998-10-22
IL123848A (en) 2002-12-01
IL123848A0 (en) 1998-10-30
WO1998043650A1 (en) 1998-10-08
US6083922A (en) 2000-07-04

Similar Documents

Publication Publication Date Title
ZA982447B (en) A method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
HUP9900150A3 (en) Inhalation device and method for inhalation of dried active pulver
EG20638A (en) Device for excision of a fistula and method of using same
AU2502395A (en) Battery-actuated insecticide transpirator and method for transpirating insecticide
IL129389A0 (en) Compounds and methods for diagnsosis of tuberculosis
AU2269499A (en) Method and device for in-situ formulation of a medicinal solution for parenteralapplication
ZA978773B (en) Method of and apparatus for treating a laminate
PL325330A1 (en) Agent for and method of fighting against harmful fungi
IL129662A0 (en) Composition for the treatment of asthma containing loratadine and a decongestant
PL329612A1 (en) Method of and agent for fighting against harmful fungi
GB2320232B (en) Satellite and Method of Operating a Satellite
GB2348144B (en) Absorbent article and method of wrapping
AU1019699A (en) A medicine for treating algomenorrhea and the method of preparation thereof
AUPO359396A0 (en) A method of treatment and pharmaceutical compositions useful for same
EP1113808A4 (en) A TREATMENT PROCEDURE AND AGENCIES SUITABLE FOR THIS
EP0776200A4 (en) AGENT AND METHOD FOR PROTECTING DRUG ADDICTION
GB2380138B (en) Absorbent article and method of wrapping
AU2554497A (en) Method and apparatus for sprayed delivery of tooth bleaching agent
AU1944295A (en) Method and device for storing a puzzle
AU2378395A (en) Method and device for destruction of objects
HUP0003476A3 (en) Method for preventing the oral misuse of a transdermal therapeutic system and a trasdermal therapeutic system containing denaturing agent
AU2295497A (en) Therapeutic and preventive method against harmful microbes
GB9701548D0 (en) A method of handling substances and a container for such substances
AU6439094A (en) Pharmaceutical agent for local application and a method of obtaining same
IL106309A0 (en) A termite-controlling agent and a controlling method thereof